|
ISH 2010 will feature a number of special symposia unique to this year’s Meeting. If you wish to attend any of the Symposia below you must be registered for ISH 2010. For more details on the confirmed Symposia, click on the links below:
Bridging the Gaps: Reducing Cardiovascular Risk in Low Resource Settings
Session Organizers: World Hypertension League (WHL) and the Chinese Hypertension League (CHL)
Session
Chairs: Dr. Arun Chockalingam and Dr. Liu Lisheng
Date: Sunday, September 26
Location: Vancouver Convention Centre, Room 109-110
Time: 9:00 - 11:30
Presentations:
The anti-hypertensive effect and mechanism of Yang-Xue-Qing-Nao Granules
Prof. Limin Hu, Tianjin University of Traditional Chinese Medicine, China
The role of berberline therapy in the association of CD31+/CD42-microparticles and endothelial dysfunction -a animal study
Prof. Jun Tao, Sun Yat-Sen University, China
Puerarin attenuates cerebral damage through improving cerebral microcirculation in SHR
Prof. Xiuhua Liu, PLA General Hospital, China
Cardiovascular Protective Effects of Herbal Medicine Danshen-Gegen - A Novel Randomised Double Blind Placebo ControlTrial in High Risk Hypertensive Subjects
Dr. Thomas Wai-Cheong Yip, Yan Chai Hospital, China
Session Organizers:
International Society of Hypertension (ISH), the World Health Organization (WHO) and the Lancet
Date: Monday, September 27
Location: Vancouver Convention Centre, Ballroom A
Time: 14:15 - 15:45
For additional information please visit the ISH website.
The International Society of Hypertension (ISH) is playing an increasing role in terms of education of both patients and physicians around the world. The Society is attempting to not only introduce best practice, but also ensure that screening for cardiovascular disease is carried out and that the epidemics of heart disease and stroke are avoided. These will inevitably occur if cardiovascular disease is not detected early. With this in mind, a special Symposium entitled Bridging the Gaps: Reducing Cardiovascular Risk in Low Resource Settings is being organised by the ISH, in collaboration with the World Health Organization (WHO) and the Lancet. This joint Symposium will take place on Sunday, September 26 and Monday, September 27 2010.
On September 26, there will be a series of meetings attended by a small delegation. This will be followed by a Plenary Session on September 27 to which we invite all delegates of the ISH 2010 meeting.
High level representation from government and WHO will be in attendance to hear a summary of the pre-conference meetings and to discuss ways in which they can help implement the programmes more extensively in their own areas. It is hoped that the findings of the Symposium, an Accord, will be signed by the Ministers of Health and published. It is the ultimate aim of the organizers to secure the commitment of Ministers to implement these programmes more extensively at the national level.
Session Organizer: NHLBI
Session Moderator: Dr. Denise Simons-Morton
Date: Tuesday, September 28
Location: Vancouver Convention Centre, Room 109-110
Time: 14:15 - 15:45
Presentations:
Overview of NHLBI activities in Hypertension Research
Denise Simons-Morton, M.D., Ph.D., Division for the Application of Research Discoveries, NHLBI, Bethesda, MD
Genetics of Hypertension
Dan Levy, M.D., Framingham Heart Study, NHLBI, Framingham, MA
Blood Pressure Trial Results from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study
William Cushman, M.D., Veterans Affairs Medical Center, Memphis, TN
Research Tested Strategies for Improving Hypertension Control in Primary Care
Beverly Green, M.D., M.P.H., Group Health Research Institute, Seattle, WA
Cardiovascular guidelines supported by the NHLBI
Eduardo Ortiz, M.D., M.P.H., Division for the Application of Research Discoveries, NHLBI, Bethesda, MD